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204 Decreasing fat-soluble vitamin deﬁciencies by increased
awareness and change of vitamin preparation
A.M. Olesen1, H. Olesen2. 1Aarhus University Hospital, Dept of Pediatrics,
Aarhus N, Denmark; 2Aarhus University Hospital, Pediatric dept, Aarhus N,
Denmark
Objectives: We prescribe AquADEKs liquid, chewables or softgels in the recom-
mended doses. This study compares the current status of plasma levels of A, D
and E vitamins in all patients with our ﬁrst assessment in 2010, where AquADEKs
chewables were not available.
Methods: Plasma levels of A, D and E vitamins in adult and paediatric CF patients
were obtained at annual assessment since 2009. Deﬁciency was described as below
lower level of normal local values (vit D 50 nmol/l; vit A 0.7 mmol/l for <7 y,
0.91 for 7 y; vit E 17mmol/l). In case of deﬁciency the cause was discussed with
patients.
Results: The mean value for vitamin D in summer was 79 and in winter 70 with
no signiﬁcant difference (p = 0.062). The results for vitamin A and E deﬁciency are
comparable to the vitamin D as shown in Table 1. In the age group 12−17 years
the vitamin A deﬁciency has decreased from 37.5% in the ﬁrst sample to 10.3%
in the recent sample and vitamin E deﬁciency has decreased from 68.8% to 30%.
At ﬁrst sample 54.4% of patients had at least one deﬁciency, reduced to 29.6% in
recent sample.
Table 1. Vitamin D deﬁciency by age group









0−5 years 40 1 (2.5%) 13 0 (0%)
6−11 years 25 3 (12%) 35 1 (2.9%)
12−17 years 33 16 (48.5%) 30 7 (23.3%)
18+ years 52 20 (38.5%) 68 17 (25%)
Conclusion: We found a signiﬁcant reduction in the number of patients with fat-
soluble vitamin deﬁciency as a result of common effort and awareness in the team.
Especially, vitamin A and E has shown more than a 50% reduction in deﬁciency.
For most patients the AquADEKs chewables are more palatable, which may result
in better adherence.
205 Folate deﬁciency in adult patients at a regional cystic ﬁbrosis (CF)
centre
L. Cassidy1, A. Morton1, C. Etherington1, D. Peckham1. 1St James’s University
Hospital, Regional Adult CF Unit, Leeds, United Kingdom
Water soluble vitamin deﬁciency is not thought to be a problem in patients with CF.
We describe serum folate levels (SFL) in an adult CF population and characterise
those needing SFL monitoring.
Methods: Retrospective review of electronic patient records (2007 to date) was used
to extract initial SFL. SFL was compared by gender, PPI use in year pre SFL, liver
disease, pancreatic and transplant status. Correlation of SFL to Hb, B12, FEV1%
predicted (FEV1), BMI and IV antibiotic use in year pre SFL (IVs) was calculated.
Optimal (5.4−24 ug/l) and suboptimal (<5.4ug/l) SFL groups were compared.
Results: 211 patients (98M/113F) had a SFL; 28.4% had sub-optimal levels.
Hb differed signiﬁcantly by SFL group, [median (IQR)] [116 (35) vs132 (39),
p = 0.009] but BMI [20.99 (3.99) vs 21.22 (4.57), p = 0.537], FEV1 [56 (34.25) vs
59 (40.75), p = 0.274], IVs [28 (69) vs 16 (55), p = 0.174) and B12 [432 (247) vs 498
(338), p = 0.125] did not. Correlations for SFL vs Hb (p = 0.01) and SFL vs B12
(p = 0.05) were positive and signiﬁcant. No signiﬁcant correlation was found for
FEV1 (positive, p = 0.158), BMI (positive, p = 0.619) or IVs (negative, p = 0.132).
SFL differed signiﬁcantly by gender [M 8.3 (6.1) vs F 7.0 (6.3), p = 0.043] but not
by pancreatic status [PS 5.0 (5.4) vs PI 7.7 (6.3), p = 0.060), transplant status [pre
7.6 (6.1) vs post 7.3 (8.2), p = 0.898], liver disease [LD 7.4 (5.9) vs no LD 7.6
(6.6), p = 0.688] or PPI use [PPI 7.8 (6.6) vs no PPI 7.4 (6.2), p = 0.171].
Conclusion: Folate deﬁciency exists in adults with CF. Low Hb, B12 and female
gender may indicate a need to monitor SFL. Further exploration of SFL looking at
genetics, gastric surgery, types of antibiotics, zinc and MCV may be useful.
206 Serum zinc concentration in cystic ﬁbrosis patients with
CFTR I1234V mutation associated with pancreatic sufﬁciency
A. Abdul Wahab1,2, A. Abu-Shahin1, M. Allangawi3, M.O.A. Rahman4,
P. Chandra5. 1Hamad Medical Corporation, Pediatrics, Doha, Qatar; 2Weill
Cornell Medical College, Doha, Qatar; 3Hamad Medical Corporation, Internal
Medicine, Doha, Qatar; 4Hamad Medical Corporation, Laboratory Medicines and
Pathology, Doha, Qatar; 5Hamad Medical Corporation, Medical Research Center,
Doha, Qatar
Objective: Zinc (Zn) has a wide range of physiologic functions, and related to
pulmonary health, immunity, and growth. Zn deﬁciency has been observed in a
subset of patients with cystic ﬁbrosis (CF). The aim of the study was to determine
serum Zn level among CF patients with CFTR I1234V mutation associated with
pancreatic sufﬁciency (PS).
Methods: Cross-sectional study of CF patients. Data on age, weight, height, body
mass index (BMI), BMI Z-score, FEV1 and chronic Pseudomonas aeruginosa
infection were collected. Serum Zn, albumin and total proteins were measured.
Results: Fifty-three CF patients (31 females) were enrolled in this study, 45 CF pa-
tients with CFTR I1234V mutation. The remaining 8 CF patients with other
mutations associated with pancreatic insufﬁciency (PI). Patients ranged from 2
to 49 years with a mean age of 15.1±9.1 years with mean plasma Zn of
0.78±0.15mcg/ml. Seven (13.2%) patients with CFTR I1234V and PS had low
Zn levels, below 0.6mcg/ml, when standard reference values were used for classiﬁ-
cation. Mean age in the Zn deﬁcient group was signiﬁcantly higher, 23.0±12.2 years
compared to that observed in the normal Zn levels group, 13.9±8.1 years
(p = 0.013). The mean FEV1 (% predicted) in the deﬁcient group was found to
be lower, 66.5±29.6% compared to patients with normal Zn levels, 81.4±20.4%
(p = 0.043). Persistent P. aeruginosa colonization was more prevalent in Zn deﬁcient
group. BMI Z-score positively associated with Zn levels.
Conclusion: These ﬁndings suggest that Zn deﬁciency can occur in patients with
CF and PS. The association of Zn levels and the frequency of P. aeruginosa isolated
in CF patients need further investigation.
207 Cow’s milk allergy in cystic ﬁbrosis children
L. Pop1, I. Ciuca1, Z. Popa2,5, B. Almajan Guta3, I. Popescu4. 1University
of Medicine and Pharmacy Victor Babes, Pediatric II Department, Timisoara,
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5University of Medicine and Pharmacy Victor Babes, Obstetric and Gynecology
Department, Timisoara, Romania
Objectives: In CF an important feature is the pancreatic insufﬁciency expressed by
steatorheea; in some cases, despite enzyme supplementation the chronic diarrhea is
poorly controlled.
Aim of study: To ﬁnd the prevalence of cow’s milk allergy among patients with
cystic ﬁbrosis.
Methods: In one year, sixty-seven children with cystic ﬁbrosis, aged 1 month to
3 years (19 infants), followed in our center were observed for CMPA. Cow’s
milk allergy was suspected in the presence of speciﬁc clinical manifestation
(gastrointestinal symptoms, cutaneous signs, respiratory features), in cases with a
suggestive medical history (failure to thrive, colics etc). In addition CMPA-speciﬁc
IgE (a and b lactoglobulin, casein) and diagnostic elimination test + food challenge
test.
Results: Among infants, CMPA was diagnosed in 47.36% (9 patients) of children,
predominantly in pancreatic insufﬁcient children (77% − CF infant with pancreatic
insufﬁciency). Toddlers (1−3 years) were diagnosed in a smaller percent, only
16.6% (8 children) proved to have CMPA, although in more than 35% of toddlers,
a positive history for CMPA diagnosis was found. Cystic ﬁbrosis patients with
pancreatic insufﬁciency associated more frequently CMPA (88.23%) than cystic
ﬁbrosis patients pancreatic sufﬁcient. The prevalence of cow’s milk allergy was
important, cumulating a 25.37% of CF patients.
Conclusion: Cow’s milk allergy was frequently found in CF children, especially as-
sociated with pancreatic insufﬁciency. The “combined” enteropathy could inﬂuence
the disease’s outcome and should be considered especially in persistent diarrhea of
CF children with correct enzyme supplementation.
